Tilray Brands, Inc. Amortization of Deferred Charges
Tilray Brands, Inc. (TLRY) reported Amortization of Deferred Charges of $19.59 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2026-07-28
- Tilray Brands, Inc. amortization of deferred charges for the quarter ending 2026-05-31 was $6.19M, a 70.09% decline year-over-year.
- Tilray Brands, Inc. amortization of deferred charges for the quarter ending 2026-02-28 was $5.11M, a 77.97% decline year-over-year.
- Tilray Brands, Inc. amortization of deferred charges for the quarter ending 2025-11-30 was $4.36M, a 80.99% decline year-over-year.
- Tilray Brands, Inc. amortization of deferred charges for the quarter ending 2025-08-31 was $3.93M, a 81.98% decline year-over-year.
- Tilray Brands, Inc. amortization of deferred charges for fiscal 2026 was $19.59M, a 77.90% decline from fiscal 2025.
- Tilray Brands, Inc. amortization of deferred charges for fiscal 2025 was $88.62M, a 4.56% increase from fiscal 2024.
- Tilray Brands, Inc. amortization of deferred charges for fiscal 2024 was $84.75M, a 9.35% decline from fiscal 2023.
- Tilray Brands, Inc. amortization of deferred charges for fiscal 2023 was $93.49M, a 18.84% decline from fiscal 2022.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month |
|---|---|---|---|---|
| 2026-05-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $11.30M derived: sum of 2 quarters · filed 2026-07-28 | $15.66M derived: sum of 3 quarters · filed 2026-07-28 | $19.59M 10-K · filed 2026-07-28 |
| 2026-02-28 | $5.11M 10-Q · filed 2026-04-01 | $9.46M derived: sum of 2 quarters · filed 2026-04-01 | $13.39M 10-Q · filed 2026-04-01 | $34.10M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-11-30 | $4.36M 10-Q · filed 2026-01-08 | $8.29M 10-Q · filed 2026-01-08 | $28.99M derived: sum of 3 quarters · filed 2026-07-28 | $52.17M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-08-31 | $3.93M 10-Q · filed 2025-10-09 | $24.63M derived: sum of 2 quarters · filed 2026-07-28 | $47.81M derived: sum of 3 quarters · filed 2026-07-28 | $70.74M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-05-31 | $20.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $43.88M derived: sum of 2 quarters · filed 2026-07-28 | $66.81M derived: sum of 3 quarters · filed 2026-07-28 | $88.62M 10-K · filed 2026-07-28 |
| 2025-02-28 | $23.18M 10-Q · filed 2026-04-01 | $46.11M derived: sum of 2 quarters · filed 2026-04-01 | $67.91M 10-Q · filed 2026-04-01 | $86.97M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-11-30 | $22.93M 10-Q · filed 2026-01-08 | $44.73M 10-Q · filed 2026-01-08 | $63.78M derived: sum of 3 quarters · filed 2026-07-28 | $85.34M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-08-31 | $21.80M 10-Q · filed 2025-10-09 | $40.86M derived: sum of 2 quarters · filed 2026-07-28 | $62.41M derived: sum of 3 quarters · filed 2026-07-28 | $84.33M derived: sum of 4 quarters · filed 2026-07-28 |
| 2024-05-31 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-28 | $40.61M derived: sum of 2 quarters · filed 2026-07-28 | $62.53M derived: sum of 3 quarters · filed 2026-07-28 | $84.75M 10-K · filed 2026-07-28 |
| 2024-02-29 | $21.56M 10-Q · filed 2025-04-08 | $43.48M derived: sum of 2 quarters · filed 2025-04-08 | $65.70M 10-Q · filed 2025-04-08 | $87.32M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $21.92M 10-Q · filed 2025-01-10 | $44.14M 10-Q · filed 2025-01-10 | $65.76M derived: sum of 3 quarters · filed 2025-07-29 | $89.28M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $22.23M 10-Q · filed 2024-10-10 | $43.84M derived: sum of 2 quarters · filed 2025-07-29 | $67.36M derived: sum of 3 quarters · filed 2025-07-29 | $91.36M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | $21.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $45.13M derived: sum of 2 quarters · filed 2025-07-29 | $69.13M derived: sum of 3 quarters · filed 2025-07-29 | $93.49M 10-K · filed 2025-07-29 |
| 2023-02-28 | $23.52M 10-Q · filed 2024-04-09 | $47.51M derived: sum of 2 quarters · filed 2024-04-09 | $71.87M 10-Q · filed 2024-04-09 | $102.72M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $24.00M 10-Q · filed 2024-01-09 | $48.35M 10-Q · filed 2024-01-09 | $79.20M derived: sum of 3 quarters · filed 2024-10-10 | $103.79M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $24.36M 10-Q · filed 2024-10-10 | $55.20M derived: sum of 2 quarters · filed 2024-10-10 | $79.80M derived: sum of 3 quarters · filed 2024-10-10 | $108.81M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $30.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $55.44M derived: sum of 2 quarters · filed 2024-07-30 | $84.45M derived: sum of 3 quarters · filed 2024-07-30 | $115.19M 10-K · filed 2024-07-30 |
| 2022-02-28 | $24.59M 10-Q · filed 2023-04-10 | $53.61M derived: sum of 2 quarters · filed 2023-04-10 | $84.34M 10-Q · filed 2023-04-10 | |
| 2021-11-30 | $29.02M 10-Q · filed 2023-01-09 | $59.76M 10-Q · filed 2023-01-09 | ||
| 2021-05-31 | $35.22M 10-K · filed 2023-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |